ArticleThe Journal of antibiotics2024

Chromatin-modifying protein 4C (CHMP4C) affects breast cancer cell growth and doxorubicin resistance as a potential breast cancer therapeutic target.

Xiaoyan Jin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.